Lassa Fever
Long-running surveillance, clinical management protocols and genomic studies of Nigeria's most persistent VHF threat.
Research
Science at the frontier of emerging infectious disease.
From genomic surveillance to clinical trials, our research programmes turn outbreaks into evidence — and evidence into preparedness.
Ebola & Filoviruses
Reference diagnostics and outbreak preparedness across the filovirus family.
Mpox
Active diagnostic confirmation and characterisation of clade I and II circulation.
Dengue & Yellow Fever
Arbovirus surveillance and serology supporting national outbreak response.
COVID-19 & Respiratory Viruses
Sustained genomic surveillance contributions to global SARS-CoV-2 datasets.
Sequencing & Bioinformatics
Whole-genome sequencing pipelines feeding national and global pathogen databases.
Research infrastructure
Purpose-built capability for high-consequence science.
Clinical Trials Unit
Dedicated infrastructure for GCP-compliant trials on emerging pathogens.
Dedicated Research Molecular Lab
Separated from diagnostic workflows to safeguard scientific integrity.
Ethics Committee (Cat. B)
Independent IRB ensuring rigorous, ethically sound research.
Mobile Laboratory
Field-deployable platform for rapid outbreak investigations.
Looking forward
Prospects for the next decade.
- Expansion of laboratory capability for preclinical studies, immunology and vaccinology.
- Strengthened diagnostic scope through BSL-3 (and future BSL-4) capacity.
- Safer management of high-priority and imported pathogens.
- Grant opportunities and global partnership networks.
- Mentorship, capacity building and exchange training programmes.
- Diagnostic innovation and technology development.